Achieve Life Sciences (ACHV)
(Delayed Data from NSDQ)
$4.60 USD
+0.04 (0.88%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $4.59 -0.01 (-0.22%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMAchieve Life Sciences, Inc. (ACHV) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$15.50 | $30.00 | $10.00 | 239.91% |
Price Target
Based on short-term price targets offered by four analysts, the average price target for Achieve Life Sciences, Inc. comes to $15.50. The forecasts range from a low of $10.00 to a high of $30.00. The average price target represents an increase of 239.91% from the last closing price of $4.56.
Analyst Price Targets (4 )
Broker Rating
Achieve Life Sciences, Inc. currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by three brokerage firms. The current ABR compares to an ABR of 1.00 a month ago based on three recommendations.
Of the three recommendations deriving the current ABR, three are Strong Buy, representing 100% of all recommendations. A month ago, Strong Buy represented 100%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 4 | 4 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
9/13/2024 | Maxim Group | Jason Mccarthy | Strong Buy | Strong Buy |
8/15/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
8/14/2024 | Lake Street Capital Markets | Thomas Flaten | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.00 |
ABR (Last week) | 1.00 |
# of Recs in ABR | 3 |
Average Target Price | $15.50 |
LT Growth Rate | NA |
Industry | Medical - Drugs |
Industry Rank by ABR | 82 of 253 |
Current Quarter EPS Est: | -0.26 |
ACHV FAQs
Achieve Life Sciences, Inc. (ACHV) currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 3 brokerage firms.
The average price target for Achieve Life Sciences, Inc. (ACHV) is $15.50. The current on short-term price targets is based on 2 reports.
The forecasts for Achieve Life Sciences, Inc. (ACHV) range from a low of $10 to a high of $30. The average price target represents a increase of $239.91 from the last closing price of $4.56.
The current UPSIDE for Achieve Life Sciences, Inc. (ACHV) is 239.91%
Based on short-term price targets offered by four analysts, the average price target for Achieve Life Sciences, Inc. comes to $15.50. The forecasts range from a low of $10.00 to a high of $30.00. The average price target represents an increase of 239.91% from the last closing price of $4.56.